Mammary Cancer
The special focus in Dr. Scott Coonrod’s lab is breast cancer, referred to as “mammary cancer” in animals. Dr. Coonrod, who is the Judy Wilpon Associate Professor of Cancer Biology, is searching for ways to stop breast cancer cells from developing by specifically turning off genes in the cancer cells that are required for cell growth.

Researchers Discover What Cancer Needs To Travel
Cancer cells must prepare for travel before invading new tissues, but new Cornell research has found a possible way to stop these cells from ever hitting the road.


Overview of the Goals of Sprecher Institue for Comparative Cancer Research 
The Sprecher Institute for Comparative Cancer Research seeks to control cancer in all species. To accomplish this goal they identify and develop new discoveries for clinical application, provide treatment for animals with cancer, and produce educational materials about cancer and our environment for professional and non-professional audiences.


Know the Warning Signs
Sometimes, dog owners may mistakenly attribute some common cancer symptoms to age, explains Dr. Lindsay Thalheim, a veterinary oncologist at Cornell University Veterinary Specialists in Stamford, CT. It’s an understandable mistake, she notes, because cancers occur most often in dogs age ten and older. Dr. Thalheim suggests taking your dog for a checkup if you notice any of these symptoms:  Unusual lumps, including new lumps that are fast-growing. Extreme lethargy. A radical change in behavior. “It can be an acute collapse, where the dog seems normal and then is so incapacitated he has to be rushed in for treatment. ”Diarrhea, vomiting, and changes in appetite–especially a refusal to eat. Persistent cough or wheezing. Enlarged lymph nodes (If you rub under a dog’s jawline you may notice the difference when they’re swollen.)  Bleeding from the nose.

Cancer Management FAQs


General Recomendations for Cancer Screening
In general, because cancer is a common disorder of older dogs and cats, animals beyond the age of 7 or 8 years of age should be considered "at risk" for cancer. General screening recommendations such as bi-annual physicals, screening laboratory bloodwork and urinalysis are becoming more common for geriatric animals.

No Bones About It:  How Dogs Can Help Advance Cancer Research

On Thursday, May 19, 2016, Dr. Robert S. Weiss, Professor of Molecular Genetics at Cornell University College of Veterinary Medicine, spoke at the Greenwich Library and discussed the latest developments in comparative oncology, and highlighted the current research efforts in cancer therapies benefiting both humans and canines. The lecture was co-sponsored by ClancysCure and Cornell.  Dr. Weiss graciously provided us with the slides from his presentation, so our followers can see them here.

Researchers Turn to Canine Clinical Trials to Advance Cancer Therapies

Journal of the American Medical Association (JAMA)   Published online March 30, 2016
About 6 million dogs are diagnosed with cancer each year, and more than half of dogs older than 10 years will develop cancers such as osteosarcoma, lymphoma, or melanoma. But the heartbreaking diagnosis for dog owners is a treasure trove of potential data for oncology researchers. In clinical trials at academic research centers across the country, veterinarians and physicians are studying how pet dogs respond to cancer therapies and analyzing the genetic makeup of these tumors. Although medicine and veterinary medicine, for the most part, have been viewed as 2 different worlds, with little exchange of information between the two, that is beginning to change.  Read the Article...

Perspectives from man’s best friend:  National Academy of Medicine’s Workshop on Comparative Oncology  Published online February 3, 2016

Dogs develop a broad spectrum of naturally occurring cancers that share strong similarities with human cancers, and, like human patients, pets receive state-of-the-art medical care that can include experimental therapeutics, thus offering a singular opportunity for preclinical modeling. A growing alliance of scientists involved in cancer research and drug development has recognized the inclusion of dogs with cancer in a comparative and integrated translational drug development path as a possible means to markedly accelerate cancer drug discovery. Read the article...


Far Reaching Benefits from Canine Cancer Research  Published online January 5, 2016

Studying the genetics of hemangiosarcoma—an incurable cancer of the cells that line blood vessels—may also lead to more information about its parallel human cancer, angiosarcoma.  A study mapping genes associated with two cancers common in golden retrievers could lead to better prevention and treatment of the disease in dogs as well as similar cancers in people.  Read the article...

Forging a New Path: Cornell Scientists Take the Lead in Lymphoma Research

Scopes Magazine, Summer 2015

Lymphoma is one of the most common cancers in dogs. It is also usually deadly; when a dog gets the disease, it is treatable, but the disease usually relapses within a year. Researchers at Cornell University College of Veterinary Medicine and Weill Cornell Medical College are working to change this. Read the article...

Cornell University One Medicine: Treating Lymphoma in Humans and Dogs

This video is informative and definitely worth watching. The topic is the co-clinical research taking place at Cornell University College of Veterinary Medicine and Weill Cornell Medical College, but its message is HOPE!   Watch the video...